Bridgebio sec filings
WebBridgeBio is a biotechnology company designing transformative medicines for patients with genetic diseases and cancers with clear genetic drivers. WebMar 23, 2024 · BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced …
Bridgebio sec filings
Did you know?
WebDec 27, 2024 · BridgeBio Pharma, Inc. Forward-Looking Statements ... drivers as well as those risks set forth in the Risk Factors section of our most recent Annual Report on Form 10-K and BridgeBio Pharma’s ... WebApr 6, 2024 · As of April 6, 2024, the average one-year price target for BridgeBio Pharma is $26.78. The forecasts range from a low of $18.18 to a high of $33.60. The average price target represents an increase ...
WebJan 13, 2024 · In addition, the documents filed by BridgeBio may be obtained free of charge from BridgeBio at investor.bridgebio.com, under the tab “Financials & Filings,” and the documents filed by Eidos ... WebMar 29, 2024 · of the Securities Exchange Act of 1934 ... (Date of earliest event reported): March 29, 2024 . BridgeBio Pharma, Inc. (Exact name of registrant as specified in its charter) Delaware : 001-38959 : 84-1850815 ... Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant ...
WebMar 29, 2024 · On March 29, 2024, QED Therapeutics, Inc. (“QED”), a subsidiary of BridgeBio Pharma, Inc. (the “Company”), entered into a license and collaboration agreement (the “License and Collaboration Agreement”) with Helsinn Healthcare S.A. (“HHC”) and Helsinn Therapeutics (U.S.), Inc. (“HTU”, collectively with HHC, “Helsinn,” … WebApr 14, 2024 · The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, CFO Brian C. Stephenson sold 17,717 shares …
WebAs of April 6, 2024, the average one-year price target for BridgeBio Pharma is $26.78. The forecasts range from a low of $18.18 to a high of $33.60. The average price target …
WebApr 11, 2024 · BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit bridgebio.com and follow us on LinkedIn and Twitter. BridgeBio Contact: Vikram Bali. … bronze nataraja of chola periodWebApr 6, 2024 · As of April 6, 2024, the average one-year price target for BridgeBio Pharma is $26.78. The forecasts range from a low of $18.18 to a high of $33.60. The average price … bronze name tagsWebMar 17, 2024 · BridgeBio was selected to share an oral presentation and posters on its ongoing Phase 2 trial with 15-month results, including the preliminary design of its pivotal Phase 3 study in patients with ... bronze nazareth good morningWebMar 8, 2024 · The shares of common stock are being offered by BridgeBio pursuant to an effective shelf registration statement on Form S-3ASR (File No. 333-239734) that was previously filed with the U.S ... bronze navalWebMar 9, 2024 · Primecap Management Co. CA owned 0.69% of BridgeBio Pharma worth $10,315,000 as of its most recent SEC filing. Several other institutional investors and hedge funds have also modified their holdings of the stock. Itau Unibanco Holding S.A. acquired a new position in shares of BridgeBio Pharma in the third quarter worth about $28,000. … bronze natural makeup lookWebApr 8, 2024 · The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. BridgeBio Pharma Stock Performance. BridgeBio's Volatile Week Puts Biotech Stocks Under a Microscope; Shares of NASDAQ BBIO traded up $0.08 during midday trading on Friday, reaching $15.61. The stock had a … tempo mega maxi nisWeb11 rows · Apr 7, 2024 · SEC Filings Group 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings Quarterly Filings Registration Statements Filing year - Any - 2024 2024 2024 2024 2024 2024 tempo jazz mikkeli